Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 199

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer

Open access
Hellebrekers, Debby M.E.I., Lentjes, Marjolein H.F.M., van den Bosch, Sandra M., Melotte, Veerle, Wouters, Kim A.D., Daenen, Kathleen L.J., Smits, Kim M., Akiyama, Yoshimitsu, Yuasa, Yasuhito, Sanduleanu, Silvia, Khalid-de Bakker, Carolina A.J., Jonkers, Daisy, Weijenberg, Matty P., Louwagie, Joost, van Criekinge, Wim, Carvalho, Beatriz, Meijer, Gerrit A., Baylin, Stephen B., Herman, James G., de Bruïne, Adriaan P., van Engeland, Manon·2009·Clinical Cancer Research

Abstract

Purpose: The transcription factors GATA4 and GATA5 are involved in gastrointestinal development and are inactivated by promoter hypermethylation in colorectal cancer. Here, we evaluated GATA4/5 promoter methylation as potential biomarkers for noninvasive colorectal cancer detection, and investigated the role of GATA4/5 in colorectal cancer. Experimental Design: Promoter methylation of GATA4/5 was analyzed in colorectal tissue and fecal DNA from colorectal cancer patients and healthy controls using methylation-specific PCR. The potential function of GATA4/5 as tumor suppressors was studied by inducing GATA4/5 overexpression in human colorectal cancer cell lines. Results: GATA4/5 methylation was observed in 70% (63/90) and 79% (61/77) of colorectal carcinomas, respectively, and was independent of clinicopathologic features. Methylation frequencies in normal colon tissues from noncancerous controls were 6% (5 of 88, GATA4; P < 0.001) and 13% (13 of 100, GATA5; P < 0.001). GATA4/5 overexpression suppressed colony formation (P < 0.005), proliferation (P < 0.001), migration (P < 0.05), invasion (P < 0.05), and anchorage-independent growth (P < 0.0001) of colorectal cancer cells. Examination of GATA4 methylation in fecal DNA from two independent series of colorectal cancer patients and controls yielded a sensitivity of 71% [95% confidence interval (95% CI), 55-88%] and specificity of 84% (95% CI, 74–95%) for colorectal cancer detection in the training set, and a sensitivity of 51% (95% CI, 37–65%) and specificity of 93% (95% CI, 84-100%) in the validation set. Conclusions: Methylation of GATA4/5 is a common and specific event in colorectal carcinomas, and GATA4/5 exhibit tumor suppressive effects in colorectal cancer cells in vitro. GATA4 methylation in fecal DNA may be of interest for colorectal cancer detection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/1078-0432.ccr-09-0055

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 199

Metadata

Authors
Hellebrekers, D. M. E. I., Lentjes, M. H. F. M., van den Bosch, S. M., Melotte, V., Wouters, K. A. D., Daenen, K. L. J., Smits, K. M., Akiyama, Y., Yuasa, Y., Sanduleanu, S., Khalid-de Bakker, C. A. J., Jonkers, D., Weijenberg, M. P., Louwagie, J., van Criekinge, W., Carvalho, B., Meijer, G. A., Baylin, S. B., Herman, J. G., de Bruïne, A. P., & van Engeland, M.
Venue
Clinical Cancer Research
Published
2009-06-15
Volume
15
Issue
12
Pages
3990-3997
ISSN
  • 1078-0432 (ISSN-L)
  • 1557-3265
OpenAlex
W2135570342
Cited by
199
References
1
FWCI
5.76
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer. https://app.cochat.ai/papers/10.1158/1078-0432.ccr-09-0055
The paper
Hellebrekers, D. M. E. I., Lentjes, M. H. F. M., van den Bosch, S. M., Melotte, V., Wouters, K. A. D., Daenen, K. L. J., Smits, K. M., Akiyama, Y., Yuasa, Y., Sanduleanu, S., Khalid-de Bakker, C. A. J., Jonkers, D., Weijenberg, M. P., Louwagie, J., van Criekinge, W., Carvalho, B., Meijer, G. A., Baylin, S. B., Herman, J. G., . . . van Engeland, M. (2009). GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer. Clinical Cancer Research. https://doi.org/10.1158/1078-0432.ccr-09-0055

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.